TY - JOUR AU - Rickles, F. R. AU - Patierno, S. AU - Fernandez, P. M. PY - 2003 DA - 2003// TI - Tissue factor, thrombin, and cancer JO - Chest VL - 124 UR - https://doi.org/10.1378/chest.124.3_suppl.58S DO - 10.1378/chest.124.3_suppl.58S ID - Rickles2003 ER - TY - JOUR AU - Kuderer, N. M. AU - Ortel, T. L. AU - Francis, C. W. PY - 2009 DA - 2009// TI - Impact of venous thromboembolism and anticoagulation on cancer and cancer survival JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.22.4584 DO - 10.1200/JCO.2009.22.4584 ID - Kuderer2009 ER - TY - JOUR AU - Bluff, J. E. AU - Brown, N. J. AU - Reed, M. W. AU - Staton, C. A. PY - 2008 DA - 2008// TI - Tissue factor, angiogenesis and tumour progression JO - Breast Cancer Res VL - 10 UR - https://doi.org/10.1186/bcr1871 DO - 10.1186/bcr1871 ID - Bluff2008 ER - TY - JOUR AU - Falanga, A. AU - Panova-Noeva, M. AU - Russo, L. PY - 2009 DA - 2009// TI - Procoagulant mechanisms in tumour cells JO - Best Pract Res Clin Haematol VL - 22 UR - https://doi.org/10.1016/j.beha.2008.12.009 DO - 10.1016/j.beha.2008.12.009 ID - Falanga2009 ER - TY - JOUR AU - Mueller, B. M. AU - Reisfeld, R. A. AU - Edgington, T. S. AU - Ruf, W. PY - 1992 DA - 1992// TI - Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis JO - Proc Natl Acad Sci USA VL - 89 UR - https://doi.org/10.1073/pnas.89.24.11832 DO - 10.1073/pnas.89.24.11832 ID - Mueller1992 ER - TY - JOUR AU - Falanga, A. AU - Marchetti, M. AU - Massi, D. AU - Merelli, B. AU - Verzeroli, C. AU - Russo, L. AU - Rulli, E. AU - Tondini, C. AU - Legramandi, L. AU - Nassini, R. AU - Scatena, C. AU - Logu, F. AU - Cattaneo, L. AU - Mandalà, M. PY - 2016 DA - 2016// TI - The thrombophilic status predicts prognosis in metastatic BRAFV600 mutated melanoma patients receiving BRAF inhibitors JO - J Am Acad Dermatol VL - 74 UR - https://doi.org/10.1016/j.jaad.2015.11.006 DO - 10.1016/j.jaad.2015.11.006 ID - Falanga2016 ER - TY - JOUR AU - Schneider, C. A. AU - Rasband, W. S. AU - Eliceiri, K. W. PY - 2012 DA - 2012// TI - NIH Image to ImageJ: 25 years of image analysis JO - Nat Methods VL - 9 UR - https://doi.org/10.1038/nmeth.2089 DO - 10.1038/nmeth.2089 ID - Schneider2012 ER - TY - JOUR AU - Menzies, A. M. AU - Long, G. V. PY - 2014 DA - 2014// TI - Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2054 DO - 10.1158/1078-0432.CCR-13-2054 ID - Menzies2014 ER - TY - JOUR AU - Lima, L. G. AU - Monteiro, R. Q. PY - 2013 DA - 2013// TI - Activation of blood coagulation in cancer: implications for tumour progression JO - Biosci Rep VL - 33 UR - https://doi.org/10.1042/BSR20130057 DO - 10.1042/BSR20130057 ID - Lima2013 ER - TY - JOUR AU - Bromberg, M. E. AU - Konigsberg, W. H. AU - Madison, J. F. PY - 1995 DA - 1995// TI - Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation JO - Proc Natl Acad Sci VL - 92 UR - https://doi.org/10.1073/pnas.92.18.8205 DO - 10.1073/pnas.92.18.8205 ID - Bromberg1995 ER - TY - JOUR AU - Fischer, E. G. AU - Ruf, W. AU - Mueller, B. M. PY - 1995 DA - 1995// TI - Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells JO - Cancer Res VL - 55 ID - Fischer1995 ER - TY - JOUR AU - Verzeroli, C. AU - Marchetti, M. AU - Merelli, B. AU - Mandalà, M. AU - Falanga, A. PY - 2013 DA - 2013// TI - Predictive value for disease progression of thrombin generation and d-dimer levels in melanoma patients receiving BRAF inhibitor therapy JO - Blood VL - 122 ID - Verzeroli2013 ER - TY - JOUR AU - Rajeshwary, G. AU - Gilda, J. E. AU - Gomes, A. V. PY - 2014 DA - 2014// TI - The necessity of and strategies for improving confidence in the accuracy of western blots JO - Expert Rev Proteom VL - 11 UR - https://doi.org/10.1586/14789450.2014.939635 DO - 10.1586/14789450.2014.939635 ID - Rajeshwary2014 ER - TY - JOUR AU - Butenas, S. AU - Orfeo, T. AU - Mann, K. G. PY - 2009 DA - 2009// TI - Tissue factor in coagulation: which? where? when? JO - Arterioscler Thromb Vasc Biol VL - 29 UR - https://doi.org/10.1161/ATVBAHA.108.177402 DO - 10.1161/ATVBAHA.108.177402 ID - Butenas2009 ER - TY - JOUR AU - Chen, V. M. AU - Hogg, P. J. PY - 2013 DA - 2013// TI - Encryption and decryption of tissue factor JO - J Thromb Haemost VL - 11 UR - https://doi.org/10.1111/jth.12228 DO - 10.1111/jth.12228 ID - Chen2013 ER - TY - JOUR AU - Butenas, S. PY - 2012 DA - 2012// TI - Tissue factor structure and function JO - Scientifica VL - 2012 UR - https://doi.org/10.6064/2012/964862 DO - 10.6064/2012/964862 ID - Butenas2012 ER - TY - JOUR AU - Bach, R. AU - Rifkin, D. B. PY - 1990 DA - 1990// TI - Expression of tissue factor procoagulant activity: regulation by cytosolic calcium JO - Proc Natl Acad Sci USA VL - 87 UR - https://doi.org/10.1073/pnas.87.18.6995 DO - 10.1073/pnas.87.18.6995 ID - Bach1990 ER - TY - JOUR AU - Bach, R. R. AU - Moldow, C. F. PY - 1997 DA - 1997// TI - Mechanism of tissue factor activation on HL-60 cells JO - Blood VL - 89 ID - Bach1997 ER - TY - JOUR AU - Mulder, A. B. AU - Smit, J. W. AU - Bom, V. J. J. AU - Blom, N. R. AU - Ruiters, M. H. J. AU - Halie, R. AU - Meer, J. PY - 1996 DA - 1996// TI - Association of smooth muscle cell tissue factor with caveolae JO - Blood VL - 88 ID - Mulder1996 ER - TY - JOUR AU - Ott, P. A. PY - 2015 DA - 2015// TI - Combined BRAF and MEK inhibition in BRAF(V600E) mutant melanoma: a synergistic and potentially safe combination partner with immunotherapy JO - Ann Transl Med VL - 3 ID - Ott2015 ER - TY - JOUR AU - Lawrence, M. C. AU - Jivan, A. AU - Shao, C. AU - Duan, L. AU - Goad, D. AU - Zaganjor, E. PY - 2008 DA - 2008// TI - The roles of MAPKs in disease JO - Cell Res VL - 18 UR - https://doi.org/10.1038/cr.2008.37 DO - 10.1038/cr.2008.37 ID - Lawrence2008 ER - TY - JOUR AU - Hu-Lieskovan, S. AU - Robert, L. AU - Homet Moreno, B. AU - Ribas, A. PY - 2014 DA - 2014// TI - Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.52.1377 DO - 10.1200/JCO.2013.52.1377 ID - Hu-Lieskovan2014 ER - TY - JOUR AU - Ott, P. A. AU - Bhardwaj, N. PY - 2013 DA - 2013// TI - Impact of MAPK pathway activation in BRAF(V600) melanoma on T cell and dendritic cell function JO - Front Immunol VL - 4 UR - https://doi.org/10.3389/fimmu.2013.00346 DO - 10.3389/fimmu.2013.00346 ID - Ott2013 ER - TY - JOUR AU - Chang, F. AU - Steelman, L. S. AU - Lee, J. T. AU - Shelton, J. G. AU - Navolanic, P. M. AU - Blalock, W. L. AU - Franklin, R. A. AU - McCubrey, J. A. PY - 2003 DA - 2003// TI - Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention JO - Leukemia VL - 17 UR - https://doi.org/10.1038/sj.leu.2402945 DO - 10.1038/sj.leu.2402945 ID - Chang2003 ER - TY - JOUR AU - López-Pedrera, C. AU - Buendía, P. AU - Cuadrado, M. J. AU - Siendones, E. AU - Aguirre, M. A. AU - Barbarroja, N. AU - Montiel-Duarte, C. AU - Torres, A. AU - Khamashta, M. AU - Velasco, F. PY - 2006 DA - 2006// TI - Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-κB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21549 DO - 10.1002/art.21549 ID - López-Pedrera2006 ER - TY - JOUR AU - Pierangeli, S. S. AU - Harris, E. N. PY - 2003 DA - 2003// TI - Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells JO - Lupus VL - 12 UR - https://doi.org/10.1191/961203303lu398oa DO - 10.1191/961203303lu398oa ID - Pierangeli2003 ER - TY - JOUR AU - Zhou, J. N. AU - Ljungdahl, S. AU - Shoshan, M. C. AU - Swedenborg, J. AU - Linder, S. PY - 1998 DA - 1998// TI - Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway JO - Mol Carcinog VL - 21 UR - https://doi.org/3.0.CO;2-K DO - 3.0.CO;2-K ID - Zhou1998 ER - TY - JOUR AU - Yu, J. L. AU - May, L. AU - Lhotak, V. AU - Shahrzad, S. AU - Shirasawa, S. AU - Weitz, J. I. AU - Coomber, B. L. AU - Mackman, N. AU - Rak, J. W. PY - 2005 DA - 2005// TI - Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2004-05-2042 DO - 10.1182/blood-2004-05-2042 ID - Yu2005 ER - TY - JOUR AU - Rossi, S. AU - Cordella, M. AU - Tabolacci, C. AU - Nassa, G. AU - D’Arcangelo, D. AU - Senatore, C. AU - Pagnotto, P. AU - Magliozzi, R. AU - Salvati, A. AU - Weisz, A. AU - Facchiano, A. AU - Facchiano, F. PY - 2018 DA - 2018// TI - TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness JO - J Exp Clin Cancer Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0982-1 DO - 10.1186/s13046-018-0982-1 ID - Rossi2018 ER -